Organisation paid for research Program year 2024 Source: CMS Open Payments

Derm Research

Neither a doctor nor a teaching hospital

Research payments

$44,091

21 payments

Through program year 2024, Derm Research is reported as receiving $44,091 in research payments, across 21 payments.

By program year

2 rows
Year Kind Amount Payments
2024 Research $41,041 19
2019 Research $3,050 2

Breakdown

Who paid Research payments · program years 2019–2024
  1. Biofrontera Bioscience GmbH $36,755 17 payments
  2. Incyte Corporation $7,336 4 payments
Studies the money was for Research payments · program years 2019–2024
  1. Ala-Ak-Ct019 $24,663 8 payments
  2. Ala-Acv-Ct014 $6,444 1 payment
  3. Ala-Acv-Ct014 $5,647 8 payments
  4. TRuE AD2-An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $3,050 2 payments
  5. TRuE AD2-An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $2,143 1 payment
  6. TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $2,143 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record